Format

Send to

Choose Destination
Mycoses. 2015 Oct;58(10):598-602. doi: 10.1111/myc.12366. Epub 2015 Sep 3.

Cerebrospinal fluid Coccidioides antigen testing in the diagnosis and management of central nervous system coccidioidomycosis.

Author information

1
University of Missouri-Kansas City, Kansas City, MO, USA.
2
Rush University School of Medicine, Chicago, IL, USA.
3
University of Texas-Houston, Houston, TX, USA.
4
Brigham and Women's Hospital/Harvard Medical School, Boston, MA, USA.
5
MiraVista Diagnostics and MiraVista Technologies, Indianapolis, IN, USA.

Abstract

The goal of this study was to report on the potential utility of cerebrospinal fluid (CSF) Coccidioides antigen testing in the diagnosis and management of Coccidioides meningitis. We retrospectively reviewed medical records of seven patients with Coccidioides meningitis who had Coccidioides antigen tests performed on CSF. In two severely immunocompromised patients, CSF Coccidioides antigen testing was helpful in the diagnosis when other testing modalities were negative. Coccidioides antigen testing was also useful in the management of patients who had progression of disease due to non-adherence, development of resistance, failure of therapy and the presence of vasculitis. Changing antigen levels helped identify disease complications in three patients that led to alterations in therapy or management. On the basis of our review of these seven patients with Coccidioides meningitis, we concluded that the Coccidioides antigen test contributed to the diagnosis and management of patients with Coccidioides meningitis.

KEYWORDS:

Coccidioides; antigen; cerebrospinal fluid; coccidioidomycosis; meningitis

PMID:
26393436
DOI:
10.1111/myc.12366
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center